Cargando…

Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome

BACKGROUND: Chronic Fatigue Syndrome (CFS) is a debilitating neuro-immune disorder of unknown etiology diagnosed by an array of clinical manifestations. Although several immunological abnormalities have been described in CFS, their heterogeneity has limited diagnostic applicability. METHODS: Immunol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Curriu, Marta, Carrillo, Jorge, Massanella, Marta, Rigau, Josepa, Alegre, José, Puig, Jordi, Garcia-Quintana, Ana M, Castro-Marrero, Jesus, Negredo, Eugènia, Clotet, Bonaventura, Cabrera, Cecilia, Blanco, Julià
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614537/ https://www.ncbi.nlm.nih.gov/pubmed/23514202 http://dx.doi.org/10.1186/1479-5876-11-68

Ejemplares similares

Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery
por: Massanella, Marta, et al.
Publicado: (2015)

Restricted infection of xenotropic murine leukemia virus-related virus in human lymphoid tissue
por: Curriu, Marta, et al.
Publicado: (2011)

Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4(+) T-cell immune recovery
por: Gómez-Mora, Elisabet, et al.
Publicado: (2017)

Antiretroviral therapy suppressed participants with low CD4(+) T-cell counts segregate according to opposite immunological phenotypes
por: Pérez-Santiago, Josué, et al.
Publicado: (2016)

Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4(+) T-cell immune recovery
por: Gómez-Mora, Elisabet, et al.
Publicado: (2017)

Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery
por: Gómez-Mora, Elisabet, et al.
Publicado: (2020)

Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function
por: Curriu, Marta, et al.
Publicado: (2012)

Susceptibility of Human Lymphoid Tissue Cultured ex vivo to Xenotropic Murine Leukemia Virus-Related Virus (XMRV) Infection
por: Curriu, Marta, et al.
Publicado: (2012)

On the steps of cell-to-cell HIV transmission between CD4 T cells
por: Puigdomènech, Isabel, et al.
Publicado: (2009)

HIV transfer between CD4 T cells does not require LFA-1 binding to ICAM-1 and is governed by the interaction of HIV envelope glycoprotein with CD4
por: Puigdomènech, Isabel, et al.
Publicado: (2008)

Remote Health Monitoring in the Workplace for Early Detection of COVID-19 Cases during the COVID-19 Pandemic Using a Mobile Health Application: COVIDApp.
por: Echeverría, Patricia, et al.
Publicado: (2021)

High Prevalence of Sarcopenia in HIV-Infected Individuals
por: Echeverría, Patricia, et al.
Publicado: (2018)

Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner
por: Echeverría, Patricia, et al.
Publicado: (2014)

Association between lipid genetic and immunological status in chronically HIV-infected patients
por: Echeverría, Patricia, et al.
Publicado: (2014)

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity
por: Bonjoch, Anna, et al.
Publicado: (2016)

The HR2 polymorphism N140I in the HIV-1 gp41 combined with the HR1 V38A mutation is associated with a less cytopathic phenotype
por: Cunyat, Francesc, et al.
Publicado: (2012)

A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV
por: Negredo, Eugènia, et al.
Publicado: (2020)

Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals
por: Molinos-Albert, Luis M, et al.
Publicado: (2014)

HIV-1 Tropism Testing in Subjects Achieving Undetectable HIV-1 RNA: Diagnostic Accuracy, Viral Evolution and Compartmentalization
por: Pou, Christian, et al.
Publicado: (2013)

Randomised Study to Assess the Efficacy and Safety of Once-Daily Etravirine-Based Regimen as a Switching Strategy in HIV-Infected Patients Receiving a Protease Inhibitor–Containing Regimen. Etraswitch Study
por: Echeverría, Patricia, et al.
Publicado: (2014)

Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and cART Composition or Intensification in Treated HIV Infected Individuals
por: Massanella, Marta, et al.
Publicado: (2014)

Prevalence of Ischemic Heart Disease and Management of Coronary Risk in Daily Clinical Practice: Results from a Mediterranean Cohort of HIV-Infected Patients
por: Echeverría, Patricia, et al.
Publicado: (2014)

SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients
por: Gutiérrez-Chamorro, Lucía, et al.
Publicado: (2021)

P04-13. Complex pattern of neutralization of cell-to-cell HIV transmission to activated CD4+T cells
por: Massanella, M, et al.
Publicado: (2009)

Impact of protease inhibitors on the evolution of urinary markers: Subanalyses from an observational cross-sectional study
por: Bonjoch, Anna, et al.
Publicado: (2016)

Low levels of anti-MPER antibodies are detectable in viremic HIV infected
por: Carrillo, J, et al.
Publicado: (2012)

Time of Progression to Osteopenia/Osteoporosis in Chronically HIV-Infected Patients: Screening DXA Scan
por: Negredo, Eugenia, et al.
Publicado: (2012)

Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies
por: Carrillo, Jorge, et al.
Publicado: (2018)

Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART
por: Puertas, Maria C., et al.
Publicado: (2016)

Aging in HIV-Infected Subjects: A New Scenario and a New View
por: Negredo, Eugenia, et al.
Publicado: (2017)

Reduced heart rate variability predicts fatigue severity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis
por: Escorihuela, Rosa María, et al.
Publicado: (2020)

Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTC
por: Ramón Santos, José, et al.
Publicado: (2014)

Antiretroviral Simplification with Darunavir/Ritonavir Monotherapy in Routine Clinical Practice: Safety, Effectiveness, and Impact on Lipid Profile
por: Santos, José R., et al.
Publicado: (2012)

Identifying the needs of older people living with HIV (≥ 50 years old) from multiple centres over the world: a descriptive analysis
por: Grosso, Tomás Martín, et al.
Publicado: (2023)

Clinical and Emotional Factors Related to Erectile Dysfunction in HIV-Infected Men
por: Fumaz, Carmina R., et al.
Publicado: (2016)

Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study
por: Abella, Eugenia, et al.
Publicado: (2022)

COVIDApp as an Innovative Strategy for the Management and Follow-Up of COVID-19 Cases in Long-Term Care Facilities in Catalonia: Implementation Study
por: Echeverría, Patricia, et al.
Publicado: (2020)

Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities
por: Trigueros, Macedonia, et al.
Publicado: (2022)

Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV‐2 mRNA‐1237 vaccine in patients with solid tumors
por: Felip, Eudald, et al.
Publicado: (2022)

Immunologic Insights on the Membrane Proximal External Region: A Major Human Immunodeficiency Virus Type-1 Vaccine Target
por: Molinos-Albert, Luis M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_navqi7cn4rjup82uj13gmdofb2